TY - JOUR
T1 - Clonal dissemination of Klebsiella pneumoniae carbapenemase KPC-3 in Long Beach, California
AU - Le, Jennifer
AU - Castanheira, Mariana
AU - Burgess, David S.
AU - McKee, Barbara
AU - Iqbal, Raza
AU - Jones, Ronald N.
PY - 2010/2
Y1 - 2010/2
N2 - Carbapenems (CARBs) are the primary treatment for infections caused by extended-spectrum beta-lacta-mase (ESBL)-producing Klebsiella pneumoniae strains. Production of a serine carbapenemase, KPC, is increasing alarmingly in the United States and is probably contributing to CARB resistance rates. We describe the clinical and molecular characteristics of four infections caused by KPC-3 K. pneumoniae strains.
AB - Carbapenems (CARBs) are the primary treatment for infections caused by extended-spectrum beta-lacta-mase (ESBL)-producing Klebsiella pneumoniae strains. Production of a serine carbapenemase, KPC, is increasing alarmingly in the United States and is probably contributing to CARB resistance rates. We describe the clinical and molecular characteristics of four infections caused by KPC-3 K. pneumoniae strains.
UR - http://www.scopus.com/inward/record.url?scp=75649147877&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=75649147877&partnerID=8YFLogxK
U2 - 10.1128/JCM.02397-09
DO - 10.1128/JCM.02397-09
M3 - Article
C2 - 20032252
AN - SCOPUS:75649147877
SN - 0095-1137
VL - 48
SP - 623
EP - 625
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
IS - 2
ER -